Literature DB >> 8377949

The effect of bupivacaine hydrochloride on skeletal muscle fiber type transformation by low frequency electrical stimulation.

M Takahashi1, H Miyamura, S Eguchi, S Homma.   

Abstract

Bupivacaine hydrochloride (bupivacaine HCl) is known to induce the degeneration and regeneration of skeletal muscles. We examined the priming effect of chronic and continuous nerve stimulation (5 Hz) on regenerating pectoralis major muscle after a single injection of bupivacaine HCl (3 mg/kg). Pectoralis muscle stimulated for 24 days after bupivacaine HCl injection contained 55.4 +/- 8.2% type 1 muscle fibers (n = 4). Control pectoralis major muscle stimulated for 34 days without bupivacaine HCl injection, in contrast, contained 37.7 +/- 5.5% type 1 fibers (n = 5). Therefore, the stimulated pectoralis major muscle with bupivacaine HCl injection contained a significantly larger number of type 1 fibers than that without bupivacaine HCl injection. Undifferentiated myosatellite cells produced by bupivacaine HCl may be primed to differentiate into type 1 cells by chronic low frequency electrical stimulation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8377949     DOI: 10.1016/0304-3940(93)90705-p

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  3 in total

1.  Partial fast-to-slow conversion of regenerating rat fast-twitch muscle by chronic low-frequency stimulation.

Authors:  Dirk Pette; Janez Sketelj; Dejan Skorjanc; Elmi Leisner; Irmtrud Traub; Fajko Bajrović
Journal:  J Muscle Res Cell Motil       Date:  2002       Impact factor: 2.698

Review 2.  Exercise-induced signal transduction and gene regulation in skeletal muscle.

Authors:  Henning Wackerhage; Niall M Woods
Journal:  J Sports Sci Med       Date:  2002-12-01       Impact factor: 2.988

3.  Clinical study of botulinum toxin A injection combined with spasmodic muscle therapeutic instrument on lower limb spasticity in patients with stroke.

Authors:  Xudong Ding; Li Huang; Qingsong Wang; Yanping Liu; Jing Zhong; Huaxian Chen
Journal:  Exp Ther Med       Date:  2017-04-24       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.